Inflammation-induced hepatotoxicity in humans

Shock

Volumn 31, Issue 2, 2009, Pages 151-156

  Ramakers, Bart P ^a   De Goeij, Moniek ^a   Van Der Hoeven, Johannes G ^a   Peters, Wilbert H M ^a   Pickkers, Peter ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cytokines; Glutathione s transferase A1 1; Hepatic injury; Inflammation; Sepsis

Indexed keywords

AMINOTRANSFERASE; DOBUTAMINE; ESCHERICHIA COLI ENDOTOXIN; GLUTATHIONE TRANSFERASE A1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENDOTOXEMIA; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODYNAMICS; HUMAN; INFLAMMATION; LIVER INJURY; LIVER TOXICITY; MALE; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK;

ADULT; AGED; ESCHERICHIA COLI; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LIVER; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 59649096501     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31818335ff     Document Type: Article

References (39)

1. Derikx JP, Poeze M, van Bijnen AA, Buurman WA, Heineman E: Evidence for intestinal and liver epithelial cell injury in the early phase of sepsis. Shock 28:544-548, 2007.
2. Dhainaut JF, Marin N, Mignon A, Vinsonneau C: Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit Care Med 29:S42-S47, 2001.
3. Bohlinger I, Leist M, Gantner F, Angermuller S, Tiegs G, Wendel A: DNA fragmentation in mouse organs during endotoxic shock. Am J Pathol 149: 1381-1393, 1996.
4. Izeboud CA, Hoebe KH, Grootendorst AF, Nijmeijer SM, van Miert AS, Witkamp RR, Rodenburg RJ: Endotoxin-induced liver damage in rats is minimized by beta 2-adrenoceptor stimulation. Inflamm Res 53:93-99, 2004.
5. Han DW: Intestinal endotoxemia as a pathogenetic mechanism in liver failure. World J Gastroenterol 8:961-965, 2002.
6. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE: The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 321:280-287, 1989.
7. Pleiner J, Heere-Ress E, Langenberger H, Sieder AE, Bayerle-Eder M, Mittermayer F, Fuchsjager-Mayrl G, Bohm J, Jansen B, Wolzt M: Adrenoceptor hyporeactivity is responsible for Escherichia coli endotoxin-induced acute vascular dysfunction in humans. Arterioscler Thromb Vase Biol 22: 95-100, 2002.
8. Pickkers P, Dorresteijn MJ, Bouw MP, van der Hoeven JG, Smits P: In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia. Circulation 114:414-421, 2006.
9. van der PT, Levi M, Dentener M, Jansen PM, Coyle SM, Braxton CC, Buurman WA, Hack CE, ten Cate JW, Lowry SF: Epinephrine exerts anticoagulant effects during human endotoxemia. J Exp Med 185:1143-1148, 1997.
10. Heemskerk S, Pickkers P, Bouw MPWJM, Draisma A, van der Hoeven JG, Peters WHM, Smits P, Russel FGM, Masereeuw R: Upregulation of renal inducible nitric oxide synthase during human endotoxemia and sepsis is associated with proximal tubule injury. Clin J Am Soc Nephrol 1:853-862, 2006.
11. Engelhardt R, Mackensen A, Galanos C, Andreesen R: Biological response to intravenously administered endotoxin in patients with advanced cancer. J Biol Response Mod 9:480-491, 1990.
12. Engelhardt R, Mackensen A, Galanos C: Phase I trial of intravenously administered endotoxin (Salmonella abortus equi) in cancer patients. Cancer Res 51:2524-2530, 1991.
13. Mackensen A, Galanos C, Wehr U, Engelhardt R: Endotoxin tolerance: regulation of cytokine production and cellular changes in response to endotoxin application in cancer patients. Eur Cytokine Netw 3:571-579, 1992.
14. Beckett GJ, Hayes JD: Glutathione S-transferases: biomedical applications. Adv Clin Chem 30:281-380, 1993.
15. Koo DJ, Zhou M, Chaudry IH, Wang P: Plasma alpha-glutathione S-transferase: a sensitive indicator of hepatocellular damage during polymicrobial sepsis. Arch Surg 135:198-203, 2000.
16. Mulder TP, Peters WH, Court DA, Jansen JB: Sandwich ELISA for glutathione S-transferase alpha 1-1: plasma concentrations in controls and in patients with gastrointestinal disorders. Clin Chem 42:416-419, 1996.
17. Trull AK, Facey SP, Rees GW, Wight DG, Noble-Jamieson G, Joughin C, Friend PJ, Alexander GJ: Serum alpha-glutathione S-transferase-a sensitive marker of hepatocellular damage associated with acute liver allograft rejection. Transplantation 58:1345-1351, 1994.
18. Giannini E, Risso D, Ceppa P, Botta F, Chiarbonello B, Fasoli A, Malfatti F, Romagnoli P, Lantieri PB, Testa R: Utility of alpha-glutathione S-transferase assessment in chronic hepatitis C patients with near normal alanine aminotransferase levels. Clin Biochem 33:297-301. 2000.
19. Higuchi H, Adachi Y, Wada H, Kanno M, Satoh T: Comparison of plasma alpha glutathione S-transferase concentrations during and after low-flow sevo-flurane or isoflurane anaesthesia. Acta Anaesthesiol Scand 45:1226-1229, 2001.
20. Sidlova K, Skalicka V, Kotaska K, Pechova M, Chada M, Bartosova J, Hribal Z, Nevoral J, Vavrova V, Prusa R: Serum alpha-glutathione S-transferase as a sensitive marker of hepatocellular damage in patients with cystic fibrosis. Physiol Res 52:361-365, 2003.
21. Knapen MF, Peters WH, Mulder TP, Steegers EA: A marker for hepatocellular damage. Lancet 355:1463-1464, 2000.
22. Bone RC: Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 268:3452-3455, 1992.
23. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273:117-123, 1995.
24. Dorresteijn MJ, van Eijk LT, Netea MG, Smits P, van der Hoeven JG, Pickkers P: Iso-osmolar prehydration shifts the cytokine response towards a more anti-inflammatory balance in human endotoxemia. J Endotoxin Res 11: 287-293, 2005.
25. Prabhakar U, Eirikis E, Davis HM: Simultaneous quantification of proinflammatory cytokines in human plasma using the LabMAP assay. J Immunol Methods 260:207-218, 2002.
26. Beckett GJ, Chapman BJ, Dyson EH, Hayes JD: Plasma glutathione S-transferase measurements after paracetamol overdose: evidence for early hepatocellular damage. Gut 26:26-31. 1985.
27. Beckett GJ, Hussey AJ, Laing I, Howie AF, Hayes JD, Strange RC, Faulder CG, Hume R: Measurements of glutathione S-transferase B1 in plasma after birth asphyxia: an early indication of hepatocellular damage. Clin Chem 35:995-999, 1989.
28. Chouker A, Martignoni A, Schauer RJ, Dugas M, Schachtner T, Kaufmann I, Setzer F, Rau HG, Lohe F, Jauch KW, et al.: Alpha-glutathione S-transferase as an early marker of hepatic ischemia/reperfusion injury after liver resection. World J Surg 29:528-534, 2005.
29. Beckett GJ, Dyson EH, Chapman BJ, Templeton AJ, Hayes JD: Plasma glutathione S-transferase measurements by radioimmunoassay: a sensitive index of hepatocellular damage in man. Clin Chim Acta 146:11-19, 1985.
30. Sakka SG: Assessing liver function. Curr Opin Crit Care 13:207-214, 2007.
31. Deng X, Stachlewitz RF, Liguori MJ, Blomme EA, Waring JF, Luyendyk JP, Maddox JF, Ganey PE, Roth RA: Modest inflammation enhances diclofenac hepatotoxicity in rats: role of neutrophils and bacterial translocation. J Pharmacol Exp Ther 319:1191-1199, 2006.
32. Netea MG, Kullberg BJ, Joosten LA, Sprong T, Verschueren I, Boerman OC, Amiot F, van den Berg WB, van der Meer JW: Lethal Escherichia coli and Salmonella typhimurium endotoxemia is mediated through different pathways. Eur J Immunol 31:2529-2538, 2001.
33. Katz S, Jimenez MA, Lehmkuhler WE, Grosfeld JL: Liver bacterial clearance following hepatic artery ligation and portacaval shunt. J Surg Res 51:267-270, 1991.
34. Laun RA, Schroder O, Schoppnies M, Roher HD, Ekkernkamp A, Schulte KM: Transforming growth factor-betal and major trauma: time-dependent association with hepatic and renal insufficiency. Shock 19:16-23, 2003.
35. Taveira da Silva AM, Kaulbach HC, Chuidian FS, Lambert DR, Suffredini AF, Danner RL: Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin. N Engl J Med 328:1457-1460, 1993.
36. van Eijk LT, Pickkers P, Smits P, van den BW, Bouw MP, van der Hoeven JG: Microvascular permeability during experimental human endotoxemia: an open intervention study. Crit Care 9:R157-R164, 2005.
37. Sprong T, Pickkers P, Geurts-Moespot A, van der Ven-Jongekrijg J, Neeleman C, Knaup M, Leroy D, Calandra T, van der Meer JW, Sweep F, et al.: Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia. Shock 27:482-187, 2007.
38. Marshall JC, Walker PM, Foster DM, Harris D, Ribeiro M, Paice J, Romaschin AD, Derzko AN: Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence. Crit Care 6:342-348, 2002.
39. Jakob SM, Ruokonen E, Takala J: Effects of dopamine on systemic and regional blood flow and metabolism in septic and cardiac surgery patients. Shock 18:8-13, 2002.